Preview Mode Links will not work in preview mode

Psychopharmacology and Psychiatry Updates

Nov 28, 2022

What are the safest and most effective medications for depression in youth with bipolar disorder? In this episode, we compare the response rates of quetiapine, olanzapine, and lurasidone for bipolar depression in youth. This episode also explains the differences in metabolic side effects and discusses the limitations of...

Nov 23, 2022

This episode discusses the pharmacologic treatments for BPSD, including the indications for using psychotropic medications as first-line treatment. It also explains when medications are ineffective and when to use them as a temporary measure.

Faculty: Lauren Gerlach, D.O.
Host: Richard Seeber, M.D.

Nov 18, 2022

What are FIASMA psychotropics? What do they have to do with COVID-19? In this episode, we discuss a recent study that compared rates of severe illness among patients who, when admitted for COVID-19, were or were not taking a FIASMA—a functional inhibitor of acid sphingomyelinase activity.

Faculty: Jim Phelps,...

Nov 13, 2022

Are antipsychotics the answer to the chaos of dementia? In this episode, we discuss the pharmacologic and nonpharmacologic treatment approaches to address BPSD, including the risks of using antipsychotics and the causes of death related to their use. 

Faculty: Lauren Gerlach, D.O. 
Host: Richard Seeber, M.D.

Nov 8, 2022

In this episode, we discuss a recent RCT on using brexpiprazole to treat borderline personality disorder. Is it safe and effective? Could brexpiprazole be the magic bullet we were waiting for? 

Faculty: Jim Phelps, M.D. 
Host: Richard Seeber, M.D.